Related by context. Frequent words. (Click for all words.) 65 Tesetaxel 65 liposomal formulation 64 Amgen discovers develops 64 Voreloxin 64 novel RNAi therapeutics 64 LNPs 64 targeting CD# 63 vivo electroporation 63 Copegus R 63 Bavituximab 63 Daclizumab 63 polymerase inhibitor 63 SNALP 63 orally bioavailable 62 Amgen discovers develops manufactures 62 Cethromycin 62 proteasome inhibitor 62 therapeutic monoclonal antibodies 62 Mipomersen 62 Captisol 62 Panzem R 62 Electroporation 62 Cobalamin 62 Brentuximab vedotin 62 Azedra 62 Carfilzomib 62 Phase III Clinical Trial 62 Golimumab 62 Thiarabine 61 Microplasmin 61 CCX# 61 SAR# [004] 61 DuraSite 61 RNAi Therapeutics 61 Preclinical Data 61 Belimumab 61 Nexavar ® 61 KRN# 61 immunotherapeutics 61 Dapagliflozin 61 Atrigel 60 TLR9 agonist 60 CORT # 60 DAVANAT 60 multi kinase inhibitor 60 refractory chronic lymphocytic 60 Antisense 60 Traficet EN 60 forodesine 60 Monoclonal Antibody 60 recombinant vaccines 60 Drug Candidate 60 inhaled formulation 60 antibody fragment 60 RNAi compounds 60 Nautilus Biotech 60 Nanobody 60 AEG# 60 siRNA therapeutics 60 Presents Positive 60 FDA Accepts 60 Aliskiren 60 optical biosensors 60 ImmunoCellular Therapeutics 60 HCV protease inhibitor 60 Amphotericin B 60 GRNVAC1 60 Recombinant Human 60 neuroprotective properties 60 ganetespib 60 calcitonin 59 Scancell 59 ALN TTR# 59 CR# vcMMAE 59 nebulization 59 RNA Interference 59 Patient Enrollment 59 Factor VIIa 59 humanized anti 59 Inovio proprietary electroporation 59 PEGylated 59 PEG SN# 59 II Clinical Trial 59 Pivotal Phase 59 Argatroban 59 Cetrorelix 59 adenovector 59 BioSilicon TM 59 Denufosol 59 Crofelemer 59 Ingenuity Pathways Analysis 59 Sym# 59 Pulmonary Arterial Hypertension 59 Poly ICR 59 cancer immunotherapies 59 exon skipping 59 INT# [002] 59 Ofatumumab 59 Elesclomol 58 BEMA TM Fentanyl 58 Initiate Phase